Shandong Xinhua Pharmaceutical Sets 28 October Board Meeting to Approve Nine-Month 2026 Results

Bulletin Express10-14

The Board of Shandong Xinhua Pharmaceutical Company Limited will convene at 9:30 a.m. on Wednesday, 28 October 2026, in the company’s conference room at No. 1 Lutai Avenue, Hi-tech District, Zibo, Shandong, China.

Key agenda: • Review and approve the unaudited consolidated results for the nine months ended 30 September 2026. • Address any additional business matters.

Current board composition: • Executive Directors: He Tongqing (Chairman), Xu Wenhui, Hou Ning • Independent Non-executive Directors: Pan Guangcheng, Zhu Jianwei, Ling Peixue, Cheung Ching Ching (Daisy) • Non-executive Director: Zhang Chengyong

The announcement was released on 14 October 2026 and carries the customary disclaimer from Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited regarding responsibility for its contents.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment